This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Momenta Pharmaceuticals Inc. (
Q4 2011 Earnings Call
February 9, 2012 10:00 am ET
Beverly Holley - Director, IR
Craig Wheeler - President & CEO
Rick Shea - SVP & CFO
Sumant Kulkarni - Bank of America
Duane Nash - Wedbush Securities
Alan Sonnenfeld - Sanford Bernstein
Ritu Baral - Canaccord
Ami Fadia - UBS
Joseph Schwartz - Leerink Swann
Jami Rubin - Goldman Sachs
Imran Babar - Cowen & Co
Good day ladies and gentlemen and welcome to the Momenta Pharmaceuticals fourth quarter and yearend 2011 earnings conference call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions) As a reminder this call maybe recorded. I would now like to introduce your host for today's conference, Beverly Holley, Director of Investor Relations. Ma’am, you may begin.
Thank you and good morning. I want to welcome all of you to Momenta’s conference call to discuss financial results for the fourth quarter and full-year 2011 and provide a corporate update. With me on the call today with prepared remarks are Craig Wheeler, President and Chief Executive Officer, and Rick Shea, Chief Financial Officer. Following our remarks, we’ll open the call to questions.
Before we begin, I’d like to mention that our call today will contain forward-looking statements about management’s future expectations, beliefs, plans and prospects. These forward-looking statement include comments about our enoxaparin sodium injection commercial prospects and our generic competitors’ prospects for approval and commercialization; our generic Copaxone program, ANDA review and patent litigation expectations; and our other project development plans and expectations, including our future development, partnering and commercialization potential for our development programs.